|
JP6261500B2
(ja)
|
2011-07-22 |
2018-01-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ヌクレアーゼ切断特異性の評価および改善
|
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
GB201506509D0
(en)
|
2015-04-16 |
2015-06-03 |
Univ Wageningen |
Nuclease-mediated genome editing
|
|
US10648020B2
(en)
|
2015-06-18 |
2020-05-12 |
The Broad Institute, Inc. |
CRISPR enzymes and systems
|
|
JP7109784B2
(ja)
|
2015-10-23 |
2022-08-01 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
遺伝子編集のための進化したＣａｓ９蛋白質
|
|
WO2017106657A1
(en)
|
2015-12-18 |
2017-06-22 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
|
CN110382692A
(zh)
|
2016-04-19 |
2019-10-25 |
博德研究所 |
新型crispr酶以及系统
|
|
EP3445853A1
(en)
|
2016-04-19 |
2019-02-27 |
The Broad Institute, Inc. |
Cpf1 complexes with reduced indel activity
|
|
KR102547316B1
(ko)
|
2016-08-03 |
2023-06-23 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
아데노신 핵염기 편집제 및 그의 용도
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
EP3526320A1
(en)
|
2016-10-14 |
2019-08-21 |
President and Fellows of Harvard College |
Aav delivery of nucleobase editors
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
GB2574769A
(en)
|
2017-03-03 |
2019-12-18 |
Univ California |
RNA Targeting of mutations via suppressor tRNAs and deaminases
|
|
JP2020510038A
(ja)
|
2017-03-09 |
2020-04-02 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
がんワクチン
|
|
EP3592853A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Suppression of pain by gene editing
|
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
|
CA3057192A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
|
WO2018213708A1
(en)
|
2017-05-18 |
2018-11-22 |
The Broad Institute, Inc. |
Systems, methods, and compositions for targeted nucleic acid editing
|
|
AU2018290843B2
(en)
*
|
2017-06-26 |
2025-04-24 |
Massachusetts Institute Of Technology |
CRISPR/Cas-adenine deaminase based compositions, systems, and methods for targeted nucleic acid editing
|
|
WO2019023680A1
(en)
|
2017-07-28 |
2019-01-31 |
President And Fellows Of Harvard College |
METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
WO2019071048A1
(en)
*
|
2017-10-04 |
2019-04-11 |
The Broad Institute, Inc. |
SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITION
|
|
KR20250107288A
(ko)
|
2017-10-16 |
2025-07-11 |
더 브로드 인스티튜트, 인코퍼레이티드 |
아데노신 염기 편집제의 용도
|
|
WO2019118949A1
(en)
|
2017-12-15 |
2019-06-20 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
CN110157727A
(zh)
|
2017-12-21 |
2019-08-23 |
中国科学院遗传与发育生物学研究所 |
植物碱基编辑方法
|
|
WO2019213257A1
(en)
|
2018-05-01 |
2019-11-07 |
Wake Forest University Health Sciences |
Lentiviral-based vectors and related systems and methods for eukaryotic gene editing
|
|
CN121555430A
(zh)
|
2018-05-11 |
2026-02-24 |
比姆医疗股份有限公司 |
使用可编程碱基编辑器系统取代病原性氨基酸的方法
|
|
EP3797160A1
(en)
|
2018-05-23 |
2021-03-31 |
The Broad Institute Inc. |
Base editors and uses thereof
|
|
KR20210028163A
(ko)
|
2018-06-04 |
2021-03-11 |
유니버시티 오브 코펜하겐 |
돌연변이 cpf1 엔도뉴클레아제
|
|
CA3102163A1
(en)
|
2018-06-26 |
2020-01-02 |
Massachusetts Institute Of Technology |
Crispr effector system based amplification methods, systems, and diagnostics
|
|
MX2020013461A
(es)
|
2018-06-26 |
2021-04-28 |
Broad Inst Inc |
Composiciones, sistemas y métodos de amplificación basados en la doble nicasa crispr.
|
|
US12522807B2
(en)
|
2018-07-09 |
2026-01-13 |
The Broad Institute, Inc. |
RNA programmable epigenetic RNA modifiers and uses thereof
|
|
KR20210055733A
(ko)
|
2018-09-07 |
2021-05-17 |
빔 테라퓨틱스, 인크. |
핵염기 편집 시스템을 전달하기 위한 조성물 및 방법
|
|
EP3850088A4
(en)
|
2018-09-07 |
2023-07-19 |
Beam Therapeutics, Inc. |
Compositions and methods for improving base editing
|
|
JP7344300B2
(ja)
|
2018-09-18 |
2023-09-13 |
ブイエヌブイ ニューコ インク． |
Ａｒｃベースのカプシドおよびその使用
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
WO2020122104A1
(ja)
|
2018-12-11 |
2020-06-18 |
国立大学法人京都大学 |
ゲノムｄｎａに欠失を誘導する方法
|
|
WO2020124050A1
(en)
|
2018-12-13 |
2020-06-18 |
The Broad Institute, Inc. |
Tiled assays using crispr-cas based detection
|
|
WO2020142739A1
(en)
*
|
2019-01-04 |
2020-07-09 |
Mammoth Biosciences, Inc. |
COMPOSITIONS AND METHODS FOR DETECTING MODIFIED NUCLEIC ACIDS AND AMPLIFYING ssDNA
|
|
EP3914261A4
(en)
|
2019-01-22 |
2023-06-28 |
Korro Bio, Inc. |
Rna-editing oligonucleotides and uses thereof
|
|
TW202043469A
(zh)
|
2019-01-22 |
2020-12-01 |
美商科羅生物公司 |
Ｒｎａ編輯之寡核苷酸及其用途
|
|
KR20210129646A
(ko)
|
2019-01-22 |
2021-10-28 |
코로 바이오, 인크. |
Rna-편집 올리고뉴클레오타이드 및 그의 용도
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
AU2020223306A1
(en)
*
|
2019-02-13 |
2021-08-05 |
Beam Therapeutics Inc. |
Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
|
|
US20220235347A1
(en)
|
2019-02-13 |
2022-07-28 |
Beam Therapeutics Inc. |
Compositions and methods for treating hemoglobinopathies
|
|
WO2020168122A1
(en)
*
|
2019-02-13 |
2020-08-20 |
Beam Therapeutics Inc. |
Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
|
|
KR20210126680A
(ko)
*
|
2019-02-13 |
2021-10-20 |
빔 테라퓨틱스, 인크. |
알파-1 항트립신 결핍증을 치료하기 위한 조성물 및 방법
|
|
US12215382B2
(en)
|
2019-03-01 |
2025-02-04 |
The General Hospital Corporation |
Liver protective MARC variants and uses thereof
|
|
WO2020186101A1
(en)
|
2019-03-12 |
2020-09-17 |
The Broad Institute, Inc. |
Detection means, compositions and methods for modulating synovial sarcoma cells
|
|
US12419915B2
(en)
|
2019-03-13 |
2025-09-23 |
The Broad Institute, Inc. |
Microglial progenitors for regeneration of functional microglia in the central nervous system and therapeutics uses thereof
|
|
WO2020186235A1
(en)
|
2019-03-14 |
2020-09-17 |
The Broad Institute, Inc. |
Compositions and methods for modulating cgrp signaling to regulate intestinal innate lymphoid cells
|
|
WO2020186231A2
(en)
|
2019-03-14 |
2020-09-17 |
The Broad Institute, Inc. |
Crispr effector system based multiplex diagnostics
|
|
US20220142948A1
(en)
|
2019-03-18 |
2022-05-12 |
The Broad Institute, Inc. |
Compositions and methods for modulating metabolic regulators of t cell pathogenicity
|
|
US20220152148A1
(en)
|
2019-03-18 |
2022-05-19 |
The Broad Institute, Inc. |
Modulation of type 2 immunity by targeting clec-2 signaling
|
|
US12534714B2
(en)
|
2019-03-18 |
2026-01-27 |
The Broad Institute, Inc. |
Type VII CRISPR proteins and systems
|
|
JP7657726B2
(ja)
|
2019-03-19 |
2025-04-07 |
ザ ブロード インスティテュート，インコーポレーテッド |
編集ヌクレオチド配列を編集するための方法および組成物
|
|
US20230193322A1
(en)
*
|
2019-04-16 |
2023-06-22 |
Arizona Board Of Regents On Behalf Of Arizona State University |
CAS9 Fusion Proteins and Related Methods
|
|
US12473543B2
(en)
|
2019-04-17 |
2025-11-18 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
US20220249701A1
(en)
|
2019-05-14 |
2022-08-11 |
The Broad Institute, Inc. |
Compositions and methods for targeting multinucleated cells
|
|
US20220251640A1
(en)
|
2019-05-17 |
2022-08-11 |
The Broad Institute, Inc. |
Methods of determination of genome architecture and epigenetic profile
|
|
US20220226464A1
(en)
|
2019-05-28 |
2022-07-21 |
Massachusetts Institute Of Technology |
Methods and compositions for modulating immune responses
|
|
WO2020241679A1
(ja)
*
|
2019-05-30 |
2020-12-03 |
国立大学法人北海道大学 |
脂質ナノ粒子
|
|
WO2020241869A1
(ja)
*
|
2019-05-30 |
2020-12-03 |
国立大学法人東京大学 |
２種の核酸塩基変換酵素が融合されたＣａｓタンパク質を利用したゲノム編集システム
|
|
AU2020322021A1
(en)
|
2019-07-30 |
2022-02-10 |
Pairwise Plants Services, Inc. |
Morphogenic regulators and methods of using the same
|
|
WO2021030627A1
(en)
|
2019-08-13 |
2021-02-18 |
The General Hospital Corporation |
Methods for predicting outcomes of checkpoint inhibition and treatment thereof
|
|
US12421557B2
(en)
|
2019-08-16 |
2025-09-23 |
The Broad Institute, Inc. |
Methods for predicting outcomes and treating colorectal cancer using a cell atlas
|
|
EP4047087A4
(en)
*
|
2019-08-19 |
2023-08-23 |
Southern Medical University |
Construction of high-fidelity crispr/ascpf1 mutant and application thereof
|
|
US20220333208A1
(en)
|
2019-09-03 |
2022-10-20 |
The Broad Institute, Inc. |
Crispr effector system based multiplex cancer diagnostics
|
|
CA3153301A1
(en)
*
|
2019-09-05 |
2021-03-11 |
Benson Hill, Inc. |
Compositions and methods for modifying genomes
|
|
WO2021056302A1
(en)
*
|
2019-09-26 |
2021-04-01 |
Syngenta Crop Protection Ag |
Methods and compositions for dna base editing
|
|
EP4034138A4
(en)
|
2019-09-27 |
2024-07-31 |
Beam Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIQUID CANCERS
|
|
US11981922B2
(en)
|
2019-10-03 |
2024-05-14 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment
|
|
US12195725B2
(en)
|
2019-10-03 |
2025-01-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating and detecting tissue specific TH17 cell pathogenicity
|
|
US11793787B2
(en)
|
2019-10-07 |
2023-10-24 |
The Broad Institute, Inc. |
Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
BR112022007125A2
(pt)
|
2019-10-17 |
2022-07-05 |
Pairwise Plants Services Inc |
Variantes de nucleases cas12a e métodos de produção e uso das mesmas
|
|
WO2021081384A1
(en)
*
|
2019-10-25 |
2021-04-29 |
Greenvenus, Llc |
Synthetic nucleases
|
|
US11844800B2
(en)
|
2019-10-30 |
2023-12-19 |
Massachusetts Institute Of Technology |
Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia
|
|
AU2020373064A1
(en)
*
|
2019-11-01 |
2022-05-26 |
Massachusetts Institute Of Technology |
Type I-B CRISPR-associated transposase systems
|
|
US12195723B2
(en)
|
2019-11-08 |
2025-01-14 |
The Broad Institute, Inc. |
Engineered antigen presenting cells and uses thereof
|
|
WO2021097118A1
(en)
*
|
2019-11-12 |
2021-05-20 |
The Broad Institute, Inc. |
Small type ii cas proteins and methods of use thereof
|
|
WO2021113270A1
(en)
|
2019-12-02 |
2021-06-10 |
Shape Therapeutics Inc. |
Therapeutic editing
|
|
US12241830B2
(en)
|
2019-12-06 |
2025-03-04 |
Broad Institute, Inc. |
Living biosensors
|
|
WO2021123397A1
(en)
*
|
2019-12-20 |
2021-06-24 |
Biogemma |
IMPROVING EFFICIENCY OF BASE EDITING USING TypeV CRISPR ENZYMES
|
|
WO2021146641A1
(en)
|
2020-01-17 |
2021-07-22 |
The Broad Institute, Inc. |
Small type ii-d cas proteins and methods of use thereof
|
|
US12165747B2
(en)
|
2020-01-23 |
2024-12-10 |
The Broad Institute, Inc. |
Molecular spatial mapping of metastatic tumor microenvironment
|
|
CN113265343B
(zh)
*
|
2020-02-14 |
2023-04-07 |
中国科学院大连化学物理研究所 |
一种重组多形汉逊酵母的构建方法及其应用
|
|
EP4121532B1
(en)
|
2020-03-17 |
2025-07-30 |
The Broad Institute, Inc. |
Crispr system high throughput diagnostic systems and methods
|
|
WO2021222318A1
(en)
*
|
2020-04-28 |
2021-11-04 |
The Broad Institute, Inc. |
Targeted base editing of the ush2a gene
|
|
DE112021002672T5
(de)
|
2020-05-08 |
2023-04-13 |
President And Fellows Of Harvard College |
Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz
|
|
WO2021231673A1
(en)
*
|
2020-05-15 |
2021-11-18 |
Korro Bio, Inc. |
Methods and compositions for the adar-mediated editing of leucine rich repeat kinase 2 (lrrk2)
|
|
CA3177380A1
(en)
*
|
2020-05-26 |
2021-12-02 |
Shape Therapeutics Inc. |
Compositions and methods for modifying target rnas
|
|
EP4168540A4
(en)
*
|
2020-06-18 |
2025-01-22 |
The Broad Institute, Inc. |
CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS AND METHODS OF USE THEREOF
|
|
CN111876418B
(zh)
*
|
2020-07-17 |
2024-02-02 |
北京希诺因生物科技有限公司 |
先天性黑蒙模型犬的建立方法
|
|
WO2022032228A1
(en)
|
2020-08-07 |
2022-02-10 |
The Broad Institute, Inc. |
Therapeutic targeting of phosphate dysregulation in cancer via the xpr1:kidins220 protein complex
|
|
KR102497690B1
(ko)
*
|
2020-09-22 |
2023-02-10 |
(주)지플러스생명과학 |
신규한 crispr 연관 단백질 및 이의 용도
|
|
WO2022065867A1
(ko)
*
|
2020-09-22 |
2022-03-31 |
(주)지플러스생명과학 |
변형된 cas12a 단백질 및 이의 용도
|
|
CN112671629B
(zh)
*
|
2020-09-24 |
2023-01-03 |
紫光云技术有限公司 |
一种云网络下专线接入的实现方法
|
|
AU2021347359A1
(en)
|
2020-09-25 |
2023-05-18 |
Beam Therapeutics Inc. |
Fratricide resistant modified immune cells and methods of using the same
|
|
CN112111471B
(zh)
*
|
2020-09-25 |
2022-05-03 |
中国科学院微生物研究所 |
广谱识别PAM序列的FnCpf1突变体及其应用
|
|
EP4240849A4
(en)
*
|
2020-11-08 |
2026-04-01 |
Wave Life Sciences Ltd |
OLIGONUCLEOTIDE COMPOSITIONS AND ASSOCIATED PROCESSES
|
|
CA3196996A1
(en)
*
|
2020-11-19 |
2022-05-27 |
Baisong Lu |
Vectors, systems and methods for eukaryotic gene editing
|
|
WO2022174108A1
(en)
*
|
2021-02-12 |
2022-08-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Synthetic cas12a for enhanced multiplex gene control and editing
|
|
WO2022180153A1
(en)
*
|
2021-02-25 |
2022-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Allele-specific genome editing of the nr2e3 mutation g56r
|
|
CN114958920A
(zh)
*
|
2021-02-25 |
2022-08-30 |
北京中因科技有限公司 |
一种新型CRISPR-Cas9系统载体及其制备方法和应用
|
|
EP4330389A4
(en)
*
|
2021-04-30 |
2025-04-30 |
Alnylam Pharmaceuticals, Inc. |
RISC REORIENTATION FOR RNA EDITING
|
|
WO2022256283A2
(en)
*
|
2021-06-01 |
2022-12-08 |
Korro Bio, Inc. |
Methods for restoring protein function using adar
|
|
CN113667734B
(zh)
*
|
2021-07-16 |
2022-05-24 |
四川大学华西医院 |
Shank3片段序列甲基化检测试剂在制备精神分裂症诊断试剂盒中的用途
|
|
TW202321454A
(zh)
*
|
2021-07-26 |
2023-06-01 |
美商夏洛克生物科學公司 |
經改良之ｃｒｉｓｐｒ－ｃａｓ技術
|
|
CN113717930A
(zh)
*
|
2021-09-07 |
2021-11-30 |
复旦大学附属华山医院 |
携带fbn1突变的颅颈动脉夹层特异诱导多能干细胞系
|
|
JP2024536088A
(ja)
*
|
2021-09-26 |
2024-10-04 |
ウェイブ ライフ サイエンシズ リミテッド |
Ｍｅｃｐ２転写物を編集するための組成物及びその方法
|
|
CN119562762A
(zh)
|
2022-04-04 |
2025-03-04 |
加利福尼亚大学董事会 |
遗传互补组合物和方法
|
|
CN114958911A
(zh)
*
|
2022-05-13 |
2022-08-30 |
吉林大学 |
利用eAID-Cas9构建的帕金森病兔模型及方法
|
|
US20250361530A1
(en)
*
|
2022-05-14 |
2025-11-27 |
The Regents Of The University Of California |
Genome editing systems for multiplexing point mutation introduction in living cells
|
|
CN114934031B
(zh)
*
|
2022-05-25 |
2023-08-01 |
广州瑞风生物科技有限公司 |
新型Cas效应蛋白、基因编辑系统及用途
|
|
CN115786456B
(zh)
*
|
2022-08-24 |
2025-11-14 |
中国科学技术大学 |
一种单链悬突双链核酸供体的制备方法及应用
|
|
WO2024156085A1
(en)
*
|
2023-01-27 |
2024-08-02 |
Syngenta Crop Protection Ag |
Mb2cas12a variants with enhanced efficiency
|
|
WO2024156084A1
(en)
*
|
2023-01-27 |
2024-08-02 |
Syngenta Crop Protection Ag |
Variants of cpf1 (cas12a) with improved activity
|
|
CN116217741B
(zh)
*
|
2023-02-27 |
2025-06-27 |
河北科技大学 |
一种高效率且低脱靶率的精确基因编辑方法
|
|
WO2024182746A1
(en)
*
|
2023-03-01 |
2024-09-06 |
Pairwise Plants Services, Inc. |
Engineered proteins and methods of use thereof
|
|
WO2024192141A1
(en)
|
2023-03-13 |
2024-09-19 |
Dana-Farber Cancer Institute, Inc. |
Treatment of cancers having a drug-resistant mesenchymal cell state
|
|
WO2024192163A2
(en)
*
|
2023-03-14 |
2024-09-19 |
Memorial Sloan-Kettering Cancer Center |
Immune cell compositions comprising gp4 modifications and uses thereof
|
|
WO2024197185A1
(en)
|
2023-03-21 |
2024-09-26 |
The Broad Institute, Inc. |
Methods and compositions for dissecting organelle physiology
|
|
WO2024226838A2
(en)
|
2023-04-25 |
2024-10-31 |
The Brigham And Women's Hospital, Inc. |
Treatment of autoimmune diseases having a pathogenic t cell state
|
|
WO2025049788A1
(en)
|
2023-08-29 |
2025-03-06 |
The Broad Institute, Inc. |
Optical genetic screens of intracellular and intercellular transcriptional circuits with perturb-fish
|
|
KR102789465B1
(ko)
*
|
2023-09-20 |
2025-04-04 |
주식회사 엔세이지 |
신규 CRISPR/Cas12a 시스템 및 그 유전자 편집 용도
|
|
WO2025096916A1
(en)
|
2023-11-03 |
2025-05-08 |
The Broad Institute, Inc. |
Multi-site editing in living cells
|
|
WO2025129158A1
(en)
|
2023-12-15 |
2025-06-19 |
The Broad Institute, Inc. |
Engineered arc delivery vesicles and uses thereof
|
|
CN117844780B
(zh)
*
|
2024-01-22 |
2024-09-17 |
广东省农业科学院设施农业研究所 |
CaPTPMKP1基因对瓜类疫霉和辣椒疫霉的抗性及应用
|
|
WO2025250808A1
(en)
|
2024-05-29 |
2025-12-04 |
The Brigham And Women’S Hospital, Inc. |
Anti-crispr delivery compositions and methods
|
|
US12428636B1
(en)
|
2024-07-08 |
2025-09-30 |
Pairwise Plants Services, Inc. |
Methods and compositions for modification of protospacer adjacent motif specificity of CAS12A
|
|
CN118685428B
(zh)
*
|
2024-08-21 |
2026-01-30 |
昆明理工大学 |
一种岷江百合cyclophilin抗菌蛋白基因LrCYP1及应用
|
